|
2025-04-02 |
2025-04-01 |
PS
Planned sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
3,782
-12.3%
70.11
USD 265,156
|
3,782
-12.3%
|
70.11
|
USD 265,156
|
|
|
2025-03-31 |
2025-03-28 |
S
Sale
|
Pauls Matthew
Non-Executive Director
|
5,937
-47.7%
71.55
USD 424,797
|
5,937
-47.7%
|
71.55
|
USD 424,797
|
|
|
2025-03-31 |
2025-03-28 |
PS
Planned sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
2,691
-8.0%
73.60
USD 198,058
|
2,691
-8.0%
|
73.60
|
USD 198,058
|
|
|
2025-03-31 |
2025-03-28 |
PS
Planned sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
9,253
-21.6%
69.52
USD 643,246
|
9,253
-21.6%
|
69.52
|
USD 643,246
|
|
|
2025-03-31 |
2025-03-28 |
PS
Planned sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
12,324
-22.4%
68.92
USD 849,386
|
12,324
-22.4%
|
68.92
|
USD 849,386
|
|
|
2025-03-31 |
2025-03-28 |
PS
Planned sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
3,394
-5.8%
67.46
USD 228,946
|
3,394
-5.8%
|
67.46
|
USD 228,946
|
|
|
2025-03-28 |
2025-03-28 |
S
Sale
|
Vivo Opportunity, LLC
Large shareholder
|
333,557
-7.0%
70.60
USD 23,549,124
|
333,557
-7.0%
|
70.60
|
USD 23,549,124
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Manning Meredith
Chief Commercial Officer
Officer
|
37,000
-44.9%
67.04
USD 2,480,436
|
37,000
-44.9%
|
67.04
|
USD 2,480,436
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Manning Meredith
Chief Commercial Officer
Officer
|
34
-0.1%
72.64
USD 2,470
|
34
-0.1%
|
72.64
|
USD 2,470
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Manning Meredith
Chief Commercial Officer
Officer
|
225
-0.5%
71.74
USD 16,142
|
225
-0.5%
|
71.74
|
USD 16,142
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Manning Meredith
Chief Commercial Officer
Officer
|
155
-0.3%
70.73
USD 10,964
|
155
-0.3%
|
70.73
|
USD 10,964
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Manning Meredith
Chief Commercial Officer
Officer
|
1,505
-3.2%
69.84
USD 105,105
|
1,505
-3.2%
|
69.84
|
USD 105,105
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Manning Meredith
Chief Commercial Officer
Officer
|
2,599
-5.2%
68.79
USD 178,780
|
2,599
-5.2%
|
68.79
|
USD 178,780
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Manning Meredith
Chief Commercial Officer
Officer
|
1,976
-3.8%
67.70
USD 133,777
|
1,976
-3.8%
|
67.70
|
USD 133,777
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Manning Meredith
Chief Commercial Officer
Officer
|
1,087
-2.1%
66.79
USD 72,602
|
1,087
-2.1%
|
66.79
|
USD 72,602
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Manning Meredith
Chief Commercial Officer
Officer
|
668
-1.2%
65.97
USD 44,067
|
668
-1.2%
|
65.97
|
USD 44,067
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Officer
|
8,044
-7.1%
70.80
USD 569,494
|
8,044
-7.1%
|
70.80
|
USD 569,494
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Officer
|
36,157
-24.2%
70.03
USD 2,531,919
|
36,157
-24.2%
|
70.03
|
USD 2,531,919
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Officer
|
25,799
-14.7%
69.07
USD 1,782,022
|
25,799
-14.7%
|
69.07
|
USD 1,782,022
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Officer
|
86
-0.1%
72.64
USD 6,247
|
86
-0.1%
|
72.64
|
USD 6,247
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Officer
|
563
-0.5%
71.74
USD 40,391
|
563
-0.5%
|
71.74
|
USD 40,391
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Officer
|
387
-0.4%
70.73
USD 27,374
|
387
-0.4%
|
70.73
|
USD 27,374
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Officer
|
3,762
-3.4%
69.84
USD 262,727
|
3,762
-3.4%
|
69.84
|
USD 262,727
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Officer
|
6,498
-5.6%
68.79
USD 446,985
|
6,498
-5.6%
|
68.79
|
USD 446,985
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Officer
|
4,940
-4.1%
67.70
USD 334,441
|
4,940
-4.1%
|
67.70
|
USD 334,441
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Officer
|
2,717
-2.2%
66.79
USD 181,473
|
2,717
-2.2%
|
66.79
|
USD 181,473
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Officer
|
1,669
-1.3%
65.97
USD 110,102
|
1,669
-1.3%
|
65.97
|
USD 110,102
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Yen Kristen
SEE REMARKS
Officer
|
23,475
-45.5%
66.95
USD 1,571,717
|
23,475
-45.5%
|
66.95
|
USD 1,571,717
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Yen Kristen
SEE REMARKS
Officer
|
50,156
-49.3%
66.00
USD 3,310,080
|
50,156
-49.3%
|
66.00
|
USD 3,310,080
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Yen Kristen
SEE REMARKS
Officer
|
91
-0.1%
72.64
USD 6,610
|
91
-0.1%
|
72.64
|
USD 6,610
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Yen Kristen
SEE REMARKS
Officer
|
597
-1.0%
71.74
USD 42,831
|
597
-1.0%
|
71.74
|
USD 42,831
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Yen Kristen
SEE REMARKS
Officer
|
411
-0.7%
70.73
USD 29,072
|
411
-0.7%
|
70.73
|
USD 29,072
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Yen Kristen
SEE REMARKS
Officer
|
3,990
-6.0%
69.84
USD 278,650
|
3,990
-6.0%
|
69.84
|
USD 278,650
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Yen Kristen
SEE REMARKS
Officer
|
6,891
-9.4%
68.79
USD 474,019
|
6,891
-9.4%
|
68.79
|
USD 474,019
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Yen Kristen
SEE REMARKS
Officer
|
5,239
-6.7%
67.70
USD 354,684
|
5,239
-6.7%
|
67.70
|
USD 354,684
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Yen Kristen
SEE REMARKS
Officer
|
2,881
-3.5%
66.79
USD 192,427
|
2,881
-3.5%
|
66.79
|
USD 192,427
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Yen Kristen
SEE REMARKS
Officer
|
1,769
-2.1%
65.97
USD 116,699
|
1,769
-2.1%
|
65.97
|
USD 116,699
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Huang Michael F.
Sr. VP of Clinical Development
Officer
|
10,000
-21.4%
70.03
USD 700,330
|
10,000
-21.4%
|
70.03
|
USD 700,330
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Huang Michael F.
Sr. VP of Clinical Development
Officer
|
19
-0.1%
72.64
USD 1,380
|
19
-0.1%
|
72.64
|
USD 1,380
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Huang Michael F.
Sr. VP of Clinical Development
Officer
|
125
-0.3%
71.74
USD 8,968
|
125
-0.3%
|
71.74
|
USD 8,968
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Huang Michael F.
Sr. VP of Clinical Development
Officer
|
86
-0.2%
70.73
USD 6,083
|
86
-0.2%
|
70.73
|
USD 6,083
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Huang Michael F.
Sr. VP of Clinical Development
Officer
|
836
-2.2%
69.84
USD 58,384
|
836
-2.2%
|
69.84
|
USD 58,384
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Huang Michael F.
Sr. VP of Clinical Development
Officer
|
1,444
-3.7%
68.79
USD 99,330
|
1,444
-3.7%
|
68.79
|
USD 99,330
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Huang Michael F.
Sr. VP of Clinical Development
Officer
|
1,098
-2.7%
67.70
USD 74,335
|
1,098
-2.7%
|
67.70
|
USD 74,335
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Huang Michael F.
Sr. VP of Clinical Development
Officer
|
604
-1.5%
66.79
USD 40,342
|
604
-1.5%
|
66.79
|
USD 40,342
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Huang Michael F.
Sr. VP of Clinical Development
Officer
|
371
-0.9%
65.97
USD 24,475
|
371
-0.9%
|
65.97
|
USD 24,475
|
|
|
2025-03-31 |
2025-03-27 |
PS
Planned sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
15,145
-21.4%
72.50
USD 1,098,013
|
15,145
-21.4%
|
72.50
|
USD 1,098,013
|
|
|
2025-03-31 |
2025-03-27 |
PS
Planned sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
24,989
-26.1%
70.18
USD 1,753,628
|
24,989
-26.1%
|
70.18
|
USD 1,753,628
|
|
|
2025-03-31 |
2025-03-27 |
PS
Planned sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
24,776
-20.5%
67.47
USD 1,671,629
|
24,776
-20.5%
|
67.47
|
USD 1,671,629
|
|
|
2025-03-31 |
2025-03-27 |
PS
Planned sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
46,214
-27.7%
66.39
USD 3,068,147
|
46,214
-27.7%
|
66.39
|
USD 3,068,147
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
73
-0.1%
72.64
USD 5,303
|
73
-0.1%
|
72.64
|
USD 5,303
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
478
-0.5%
71.74
USD 34,293
|
478
-0.5%
|
71.74
|
USD 34,293
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
329
-0.3%
70.73
USD 23,272
|
329
-0.3%
|
70.73
|
USD 23,272
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
3,198
-3.2%
69.84
USD 223,339
|
3,198
-3.2%
|
69.84
|
USD 223,339
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
5,524
-5.3%
68.79
USD 379,985
|
5,524
-5.3%
|
68.79
|
USD 379,985
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
4,199
-3.9%
67.70
USD 284,275
|
4,199
-3.9%
|
67.70
|
USD 284,275
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
2,310
-2.1%
66.79
USD 154,289
|
2,310
-2.1%
|
66.79
|
USD 154,289
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
1,418
-1.3%
65.97
USD 93,544
|
1,418
-1.3%
|
65.97
|
USD 93,544
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Executive Director
|
199,226
-25.7%
69.30
USD 13,805,904
|
199,226
-25.7%
|
69.30
|
USD 13,805,904
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Executive Director
|
8,423
-1.1%
67.37
USD 567,458
|
8,423
-1.1%
|
67.37
|
USD 567,458
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Executive Director
|
209,689
-21.1%
66.33
USD 13,908,797
|
209,689
-21.1%
|
66.33
|
USD 13,908,797
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Executive Director
|
106,471
-9.7%
65.81
USD 7,007,059
|
106,471
-9.7%
|
65.81
|
USD 7,007,059
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Executive Director
|
732
-0.1%
72.64
USD 53,172
|
732
-0.1%
|
72.64
|
USD 53,172
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Executive Director
|
4,782
-0.8%
71.74
USD 343,076
|
4,782
-0.8%
|
71.74
|
USD 343,076
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Executive Director
|
3,291
-0.6%
70.73
USD 232,786
|
3,291
-0.6%
|
70.73
|
USD 232,786
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Executive Director
|
31,980
-5.2%
69.84
USD 2,233,390
|
31,980
-5.2%
|
69.84
|
USD 2,233,390
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Executive Director
|
55,234
-8.2%
68.79
USD 3,799,442
|
55,234
-8.2%
|
68.79
|
USD 3,799,442
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Executive Director
|
41,989
-5.9%
67.70
USD 2,842,685
|
41,989
-5.9%
|
67.70
|
USD 2,842,685
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Executive Director
|
23,095
-3.1%
66.79
USD 1,542,552
|
23,095
-3.1%
|
66.79
|
USD 1,542,552
|
|
|
2025-03-31 |
2025-03-27 |
S
Sale
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Executive Director
|
14,183
-1.9%
65.97
USD 935,640
|
14,183
-1.9%
|
65.97
|
USD 935,640
|
|
|
2025-03-28 |
2025-03-27 |
S
Sale
|
Vivo Opportunity, LLC
Large shareholder
|
1,100,000
-18.7%
67.80
USD 74,580,000
|
1,100,000
-18.7%
|
67.80
|
USD 74,580,000
|
|
|
2025-03-28 |
2025-03-26 |
S
Sale
|
Vivo Opportunity, LLC
Large shareholder
|
400,000
-6.4%
65.80
USD 26,320,000
|
400,000
-6.4%
|
65.80
|
USD 26,320,000
|
|
|
2025-01-06 |
2025-01-03 |
S
Sale
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Officer
|
3,791
-3.3%
46.18
USD 175,055
|
3,791
-3.3%
|
46.18
|
USD 175,055
|
|
|
2025-01-06 |
2025-01-03 |
S
Sale
|
Yen Kristen
SEE REMARKS
Officer
|
2,340
-3.0%
46.18
USD 108,053
|
2,340
-3.0%
|
46.18
|
USD 108,053
|
|
|
2025-01-06 |
2025-01-03 |
S
Sale
|
Hirano Patricia C
SEE REMARKS
Officer
|
1,459
-1.4%
46.18
USD 67,371
|
1,459
-1.4%
|
46.18
|
USD 67,371
|
|
